What is Theophylline used for?

Theophylline is a well-established medication primarily known for its use in respiratory diseases. Its trade names include Theo-Dur, Uniphyllin, and Slo-Bid, among others. The drug is a xanthine derivative and functions primarily as a bronchodilator, making it particularly useful for managing conditions such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). Research into Theophylline has been extensive, mainly conducted by various academic and clinical research institutions focusing on respiratory and cardiovascular health. Although newer medications have emerged, Theophylline remains a cornerstone in the treatment of pulmonary disorders due to its effectiveness and affordability.

The mechanism of action for Theophylline is multifaceted, which contributes to its versatility in treating respiratory conditions. Primarily, Theophylline works by inhibiting the enzyme phosphodiesterase (PDE), resulting in an increase in intracellular cyclic adenosine monophosphate (cAMP). Elevated levels of cAMP lead to the relaxation of bronchial smooth muscle and dilation of the airways, thus easing breathing. Additionally, Theophylline exhibits anti-inflammatory properties, which further aids in reducing the symptoms associated with asthma and COPD. The medication also promotes diaphragmatic contractility, which can improve respiratory muscle function, especially in patients with chronic respiratory diseases.

 

Researching Theophylline beyond the basics?

Synapse Hiro LS Researcher, the Synapse AI Insight Engine, is built to accelerate biopharma decisions. Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence. Explore Theophylline with Hiro LS Researcher →

Theophylline can be administered in various forms, including oral tablets, capsules, extended-release formulations, liquids, and intravenous injections. The method of administration typically depends on the severity of the condition and the patient's specific needs. For instance, oral tablets and extended-release capsules are commonly used for long-term management, while intravenous injections are reserved for acute exacerbations requiring immediate intervention. The onset time for oral Theophylline is generally 1-2 hours, with peak effects occurring within 4-6 hours. Extended-release formulations provide a more prolonged therapeutic effect, making them suitable for maintaining baseline bronchial dilation over a 24-hour period.

Despite its therapeutic benefits, Theophylline is associated with a range of side effects, which can vary in severity. Common side effects include nausea, vomiting, diarrhea, headaches, and insomnia. More serious adverse effects may involve tachycardia, arrhythmias, seizures, and even severe allergic reactions. These side effects are often dose-dependent, emphasizing the importance of careful dosing and monitoring. Contraindications for Theophylline use include hypersensitivity to xanthines, peptic ulcer disease, and certain cardiac arrhythmias. Patients with underlying conditions such as liver or kidney disease, hyperthyroidism, and epilepsy should use Theophylline with caution, as these conditions can exacerbate the drug's side effects or alter its metabolism.

Various drugs can interact with Theophylline, potentially affecting its efficacy and safety profile. Medications such as cimetidine, erythromycin, and ciprofloxacin can increase Theophylline levels in the blood, raising the risk of toxicity. Conversely, drugs like phenobarbital, phenytoin, and rifampin can decrease Theophylline concentrations, reducing its therapeutic effects. Additionally, lifestyle factors such as smoking can influence Theophylline metabolism. Nicotine accelerates the breakdown of Theophylline, necessitating higher doses to achieve the desired therapeutic outcome. Therefore, it is crucial for patients to inform their healthcare providers of all medications and lifestyle habits to ensure optimal management of their respiratory conditions with Theophylline. 

In conclusion, Theophylline continues to play a significant role in the management of respiratory diseases, despite the advent of newer medications. Its multifaceted mechanism of action, various administration methods, and extensive research backing make it a valuable tool in treating asthma, chronic bronchitis, and COPD. However, the potential for side effects and drug interactions necessitates careful monitoring and patient education to maximize its therapeutic benefits while minimizing risks.

Continue your Theophylline research with Synapse Hiro LS Researcher

This article provides an overview. For a broader research view, use Synapse Hiro LS Researcher—the Synapse AI Insight Engine—to search across drugs, targets, indications, clinical trials, literature, organizations, news, deals, and competitor signals. Ask any biopharma research question in natural language.

Questions to explore:

• What approved and investigational uses have been reported for Theophylline?
• What is the mechanism of action of Theophylline, and which targets or pathways are involved?
• Which clinical trials are evaluating Theophylline, and what outcomes have been reported?
• What patents, publications, and regulatory sources provide the latest evidence on Theophylline?

Ask Synapse Hiro LS Researcher →

AI may make mistakes. Check important info.